Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10329 | 31387169 | Biomed Pharmacother | Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum. | 2019 | Details |
| A10330 | 31387054 | Phytomedicine | The combination of Ilexhainanoside D and ilexsaponin A1 reduces liver inflammation and improves intestinal barrier function in mice with high-fat diet-induced non-alcoholic fatty liver disease. | 2019 | Details |
| A10331 | 31386691 | PLoS One | Plasma ApoE elevations are associated with NAFLD: The PREVEND Study. | 2019 | Details |
| A10332 | 31386565 | Am J Physiol Endocrinol Metab | Adipocyte-specific deletion of IL-6 does not attenuate obesity-induced weight gain or glucose intolerance in mice. | 2019 | Details |
| A10333 | 31386258 | Liver Int | Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion. | 2019 | Details |
| A10334 | 31385465 | Cancer Med | Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China. | 2019 | Details |
| A10335 | 31384602 | Clin Nutr Res | The Effect of Nutrition Education Program on Overweight/Obese Patients with Non-Alcoholic Fatty Liver Disease: a Single-Blind Parallel Randomized Controlled Trial. | 2019 | Details |
| A10336 | 31384598 | Clin Nutr Res | Does Turmeric/curcumin Supplementation Change Anthropometric Indices in Patients with Non-alcoholic Fatty Liver Disease? A Systematic Review and Meta-analysis of Randomized Controlled Trials. | 2019 | Details |
| A10337 | 31384535 | Acta Pharm Sin B | Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway. | 2019 | Details |
| A10338 | 31384531 | Acta Pharm Sin B | Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters. | 2019 | Details |
| A10339 | 31384519 | Biosci Microbiota Food Health | The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms. | 2019 | Details |
| A10340 | 31383835 | Acta Med Indones | The Risk of Developing Non-Alcoholic Fatty Liver Disease in Adult Patients with Subclinical Hypothyroidism Compared to Euthyroid: An Evidence-based Case Report. | 2019 | Details |
| A10341 | 31383290 | Tissue Cell | Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice. | 2019 | Details |
| A10342 | 31382287 | Ann Intern Med | How Would You Manage This Patient With Nonalcoholic Fatty Liver Disease?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. | 2019 | Details |
| A10343 | 31381969 | J Steroid Biochem Mol Biol | Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease. | 2019 | Details |
| A10345 | 31380833 | J Vis Exp | Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells. | 2019 | Details |
| A10347 | 31380438 | Biomed Res Int | The Level of Vitamin D in Children and Adolescents with Nonalcoholic Fatty Liver Disease: A Meta-Analysis. | 2019 | Details |
| A10348 | 31380156 | Curr Hepatol Rep | Pathogenesis of NASH: The Impact of Multiple Pathways. | 2018 | Details |
| A10349 | 31379820 | Front Immunol | Tissue Immune Cells Fuel Obesity-Associated Inflammation in Adipose Tissue and Beyond. | 2019 | Details |
| A10350 | 31379558 | Front Aging Neurosci | Liver Dysfunction as a Novel Player in Alzheimer's Progression: Looking Outside the Brain. | 2019 | Details |
| A10351 | 31379412 | J Clin Biochem Nutr | Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice. | 2019 | Details |
| A10353 | 31378982 | Hepatology | Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10354 | 31378768 | J Toxicol Sci | Immunohistochemical expression of autophagosome markers LC3 and p62 in preneoplastic liver foci in high fat diet-fed rats. | 2019 | Details |
| A10356 | 31377187 | Nutr Metab Cardiovasc Dis | PNPLA3 gene polymorphism in Brazilian patients with type 2 diabetes: A prognostic marker beyond liver disease? | 2019 | Details |
| A10357 | 31376083 | Dig Dis Sci | Pocket-Sized Versus Conventional Ultrasound for Detecting Fatty Infiltration of the Liver. | 2019 | Details |
| A10358 | 31375753 | Sci Rep | A Randomised Controlled Trial on the Effectiveness and Adherence of Modified Alternate-day Calorie Restriction in Improving Activity of Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10359 | 31375359 | Mol Ther | A Mitochondrial VDAC1-Based Peptide Greatly Suppresses Steatosis and NASH-Associated Pathologies in a Mouse Model. | 2019 | Details |
| A10360 | 31375010 | Int J Environ Res Public Health | Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10361 | 31374969 | Nutrients | Melon GliSODin® Prevents Diet-Induced NASH Onset by Reducing Fat Synthesis and Improving Liver Function. | 2019 | Details |
| A10362 | 31374827 | Medicines (Basel) | Perspectives on Interval Exercise Interventions for Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10364 | 31373710 | Aliment Pharmacol Ther | Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease. | 2019 | Details |
| A10365 | 31373184 | J Korean Med Sci | Non-Alcoholic Fatty Liver Disease and Its Association with Depression in Korean General Population. | 2019 | Details |
| A10366 | 31372873 | Obes Surg | Laparoscopic Sleeve Gastrectomy on the Horizon as a Promising Treatment Modality for NAFLD. | 2020 | Details |
| A10367 | 31372694 | Naunyn Schmiedebergs Arch Pharmacol | Chrysin ameliorates nonalcoholic fatty liver disease in rats. | 2019 | Details |
| A10368 | 31372513 | Commun Biol | Ability of prebiotic polysaccharides to activate a HIF1α-antimicrobial peptide axis determines liver injury risk in zebrafish. | 2019 | Details |
| A10369 | 31372020 | Diabetes Metab Syndr Obes | Abdominal subcutaneous fat thickness and homeostasis model assessment of insulin resistance as simple predictors of nonalcoholic steatohepatitis. | 2019 | Details |
| A10370 | 31371265 | Nutr Metab Cardiovasc Dis | Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype. | 2019 | Details |
| A10371 | 31369716 | J Dent Res | Oral Diseases Associated with Nonalcoholic Fatty Liver Disease in the United States. | 2019 | Details |
| A10372 | 31369606 | PLoS One | Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis. | 2019 | Details |
| A10373 | 31367159 | World J Gastroenterol | Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis via gut microbiota. | 2019 | Details |
| A10374 | 31366982 | Sci Rep | Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis. | 2019 | Details |
| A10375 | 31366865 | Biol Pharm Bull | Cranberry Attenuates Progression of Non-alcoholic Fatty Liver Disease Induced by High-Fat Diet in Mice. | 2019 | Details |
| A10376 | 31366800 | Intern Med | Immunoglobulin G4-related Liver Disease Overlapping with Non-alcoholic Steatohepatitis That Was Diagnosed Simultaneously with Autoimmune Pancreatitis: A Case Report and Review of the Literature. | 2019 | Details |
| A10377 | 31366455 | Gut | Epidemiology of chronic liver diseases in the USA in the past three decades. | 2019 | Details |
| A10378 | 31366243 | FASEB J | Long-term exercise prevents hepatic steatosis: a novel role of FABP1 in regulation of autophagy-lysosomal machinery. | 2019 | Details |
| A10379 | 31364723 | Int J Mol Med | Green tea polyphenols attenuate hepatic steatosis, and reduce insulin resistance and inflammation in high-fat diet-induced rats. | 2019 | Details |
| A10380 | 31363910 | Hepatol Int | Reversal of NASH fibrosis with pharmacotherapy. | 2019 | Details |
| A10381 | 31362807 | Euro Surveill | Mortality rates among individuals diagnosed with hepatitis C virus (HCV); an observational cohort study, England, 2008 to 2016. | 2019 | Details |
| A10382 | 31362471 | Korean J Intern Med | The quality of non-alcoholic fatty liver disease information resources for patients on the internet in Korea. | 2019 | Details |
| A10383 | 31361543 | Am J Physiol Endocrinol Metab | eNOS deletion impairs mitochondrial quality control and exacerbates Western diet-induced NASH. | 2019 | Details |
| A10384 | 31361524 | FASEB J | Maslinic acid protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/AMPK signaling pathway. | 2019 | Details |
| A10385 | 31361003 | Nutr Rev | Effect of dietary intervention, with or without co-interventions, on inflammatory markers in patients with nonalcoholic fatty liver disease: a systematic literature review. | 2019 | Details |
| A10386 | 31360108 | Int J Biol Sci | Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer. | 2019 | Details |
| A10387 | 31360022 | J Clin Exp Hepatol | The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation. | 2018 | Details |
| A10388 | 31359543 | J Intern Med | Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study. | 2019 | Details |
| A10390 | 31359195 | Surg Endosc | Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease. | 2019 | Details |
| A10391 | 31358770 | Nat Commun | ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy. | 2019 | Details |
| A10392 | 31357780 | Zhonghua Gan Zang Bing Za Zhi | [A new attempt with lipoprotein lipase agonists in the treatment of nonalcoholic steatohepatitis]. | 2019 | Details |
| A10393 | 31357755 | Zhonghua Gan Zang Bing Za Zhi | [Machanism and intervention of nonalcoholic steatohepatitis-associated fibrosis]. | 2019 | Details |
| A10394 | 31357643 | Int J Mol Sci | Association between Lysosomal Dysfunction and Obesity-Related Pathology: A Key Knowledge to Prevent Metabolic Syndrome. | 2019 | Details |
| A10395 | 31356989 | Biochim Biophys Acta Gene Regul Mech | An interaction between MKL1, BRG1, and C/EBPβ mediates palmitate induced CRP transcription in hepatocytes. | 2019 | Details |
| A10396 | 31356578 | Transplantation | Donor PNPLA3 and TM6SF2 Variant Alleles Confer Additive Risks for Graft Steatosis After Liver Transplantation. | 2020 | Details |
| A10397 | 31355570 | Zhongguo Zhong Yao Za Zhi | [Psoralen and isopsoralen improve lipid metabolism disorder via inhibition of NF-κB activation in LO2 cells]. | 2019 | Details |
| A10398 | 31355279 | Biomed Res Int | Hepatoprotective Effect of Jianpi Huoxue Formula on Nonalcoholic Fatty Liver Disease Induced by Methionine-Choline-Deficient Diet in Rat. | 2019 | Details |
| A10399 | 31354839 | Stem Cells Int | Kupffer Cells Promote the Differentiation of Adult Liver Hematopoietic Stem and Progenitor Cells into Lymphocytes via ICAM-1 and LFA-1 Interaction. | 2019 | Details |
| A10400 | 31354322 | Diabetes Metab Syndr Obes | Obesity, adipocyte hypertrophy, fasting glucose, and resistin are potential contributors to nonalcoholic fatty liver disease in South Asian women. | 2019 | Details |
| A10401 | 31353974 | Expert Rev Gastroenterol Hepatol | Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations. | 2019 | Details |
| A10402 | 31353118 | J Formos Med Assoc | Higher NAFLD fibrosis score is associated with impaired eGFR. | 2019 | Details |
| A10403 | 31352173 | Cytokine | Chemokine ligand 20 (CCL20) expression increases with NAFLD stage and hepatic stellate cell activation and is regulated by miR-590-5p. | 2019 | Details |
| A10405 | 31352092 | Clin Gastroenterol Hepatol | Clinically Significant Fibrosis Is Associated With Longitudinal Increases in Fibrosis-4 and Nonalcoholic Fatty Liver Disease Fibrosis Scores. | 2019 | Details |
| A10406 | 31351021 | Diabetes Metab Res Rev | C-peptide is associated with NAFLD inflammatory and fibrotic progression in type 2 diabetes. | 2019 | Details |
| A10407 | 31349604 | Nutrients | Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD). | 2019 | Details |
| A10408 | 31349549 | J Clin Med | Nutrition in Gastrointestinal Disease: Liver, Pancreatic, and Inflammatory Bowel Disease. | 2019 | Details |
| A10409 | 31348282 | Medicine (Baltimore) | Association between red cell distribution width-to-platelet ratio and hepatic fibrosis in nonalcoholic fatty liver disease: A cross-sectional study. | 2019 | Details |
| A10410 | 31347470 | Tissue Eng Part A | In Vitro Production of Human Ballooned Hepatocytes in a Cell Sheet-based Three-dimensional Model. | 2019 | Details |
| A10411 | 31347138 | Infection | Epidemiological and etiological variations in hepatocellular carcinoma. | 2019 | Details |
| A10413 | 31345778 | Lancet Gastroenterol Hepatol | Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial. | 2019 | Details |
| A10414 | 31345776 | Lancet Diabetes Endocrinol | Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. | 2019 | Details |
| A10415 | 31345163 | BMC Gastroenterol | Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial. | 2019 | Details |
| A10416 | 31344854 | J Clin Med | Gut Microbiota and Risk of Persistent Nonalcoholic Fatty Liver Diseases. | 2019 | Details |
| A10417 | 31344750 | Hepatology | Mitochondrial General Control of Amino Acid Synthesis 5 Like 1 Regulates Glutaminolysis, Mammalian Target of Rapamycin Complex 1 Activity, and Murine Liver Regeneration. | 2019 | Details |
| A10419 | 31343128 | Pediatr Endocrinol Diabetes Metab | Usefulness of the metabolic syndrome diagnosis in obese children in clinical practice. | 2019 | Details |
| A10420 | 31343116 | Obesity (Silver Spring) | Novel Strategies to Treat Hepatic Steatosis and Steatohepatitis. | 2019 | Details |
| A10421 | 31343010 | Food Funct | Oral α-lipoic acid supplementation in patients with non-alcoholic fatty liver disease: effects on adipokines and liver histology features. | 2019 | Details |
| A10422 | 31342672 | Obes Rev | A systematic review and meta-analysis estimating the population prevalence of comorbidities in children and adolescents aged 5 to 18 years. | 2019 | Details |
| A10423 | 31342533 | Aliment Pharmacol Ther | Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program. | 2019 | Details |
| A10424 | 31341886 | Biomed Res Int | Sex, Age, and BMI Modulate the Association of Physical Examinations and Blood Biochemistry Parameters and NAFLD: A Retrospective Study on 1994 Cases Observed at Shuguang Hospital, China. | 2019 | Details |
| A10425 | 31341532 | Oxid Med Cell Longev | Dietary Glycotoxins Impair Hepatic Lipidemic Profile in Diet-Induced Obese Rats Causing Hepatic Oxidative Stress and Insulin Resistance. | 2019 | Details |
| A10426 | 31341444 | Integr Med (Encinitas) | Non-Alcoholic Fatty Liver Disease, an Overview. | 2019 | Details |
| A10427 | 31341422 | Mediators Inflamm | Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10428 | 31341404 | Int J Med Sci | Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease. | 2019 | Details |
| A10429 | 31340202 | J Endocrinol | Prenatal caffeine exposure induces liver developmental dysfunction in offspring rats. | 2019 | Details |
| A10430 | 31338830 | Eur J Clin Invest | Nonalcoholic fatty liver disease increases the risk of gastroesophageal reflux disease: A systematic review and meta-analysis. | 2019 | Details |
| A10431 | 31338545 | Diabetologia | A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial. | 2019 | Details |
| A10432 | 31338065 | Front Endocrinol (Lausanne) | Resveratrol Reduces Glucolipid Metabolic Dysfunction and Learning and Memory Impairment in a NAFLD Rat Model: Involvement in Regulating the Imbalance of Nesfatin-1 Abundance and Copine 6 Expression. | 2019 | Details |
| A10433 | 31337855 | Sci Rep | Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma. | 2019 | Details |
| A10434 | 31337151 | Int J Mol Sci | The Number of Liver Galectin-3 Positive Cells Is Dually Correlated with NAFLD Severity in Children. | 2019 | Details |
| A10435 | 31336926 | Nutrients | The Potential Use of Metabolic Cofactors in Treatment of NAFLD. | 2019 | Details |
| A10436 | 31336557 | Diabetes Metab Syndr | Effect of diet-induced weight loss on cytokeratin-18 levels in overweight and obese patients with liver fibrosis. | 2019 | Details |
| A10437 | 31336526 | Diabetes Metab Syndr | Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran. | 2019 | Details |